{"entity":{"type":"insider","cik":"0001354434","url":"/insider/0001354434","json_url":"/insider/0001354434.json","name":"Renaud Ronald C JR","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":4,"first":"2008-03-11","last":"2023-08-07","span_basis":"filed_date"},"name_variants":[{"name":"Renaud Ronald C JR","source":"filing","n_filings":4,"first_seen":"2008-03-11","last_seen":"2023-08-07"}],"transactions":[{"id":8310799,"accession":"0000950170-23-039169","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-039169","line_url":"/filing/0000950170-23-039169#line-1","is_derivative":false,"issuer_cik":"0001354434","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001354434","owner_cik":"0001354434","owner_name":"Renaud Ronald C JR","owner_display_name":"Renaud Ronald C JR","owner_url":"/insider/0001354434","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":83857.0,"shares_display":"83,857","price_per_share":23.9552,"price_display":"23.96","price_state":"stated","total_value":2008811.2064,"total_display":"2,008,811.21","total_whole":"2,008,811","shares_owned_after":83857.0,"shares_owned_after_display":"83,857","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-03","filed_date":"2023-08-07","scope":"insider"},{"id":4740986,"accession":"0001209191-21-056062","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-056062","line_url":"/filing/0001209191-21-056062","is_derivative":false,"issuer_cik":"0001354434","issuer_name":"Translate Bio, Inc.","issuer_ticker":"TBIO","issuer_name_source":null,"issuer_url":"/issuer/0001354434","owner_cik":"0001354434","owner_name":"Renaud Ronald C JR","owner_display_name":"Renaud Ronald C JR","owner_url":"/insider/0001354434","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":954053.0,"shares_display":"954,053","price_per_share":38.0,"price_display":"38.00","price_state":"stated","total_value":36254014.0,"total_display":"36,254,014.00","total_whole":"36,254,014","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-14","filed_date":"2021-09-14","scope":"insider","n_lines":3},{"id":7055685,"accession":"0001209191-14-072478","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-072478","line_url":"/filing/0001209191-14-072478#line-1","is_derivative":false,"issuer_cik":"0001354434","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001354434","owner_cik":"0001354434","owner_name":"Renaud Ronald C JR","owner_display_name":"Renaud Ronald C JR","owner_url":"/insider/0001354434","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":11.9173,"price_display":"11.92","price_state":"stated","total_value":59586.5,"total_display":"59,586.50","total_whole":"59,587","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-02","filed_date":"2014-12-02","scope":"insider"},{"id":2622260,"accession":"0001209191-08-017195","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-017195","line_url":"/filing/0001209191-08-017195#line-1","is_derivative":false,"issuer_cik":"0001093649","issuer_name":"IDENIX PHARMACEUTICALS INC","issuer_ticker":"IDIX","issuer_name_source":null,"issuer_url":"/issuer/0001093649","owner_cik":"0001354434","owner_name":"Renaud Ronald C JR","owner_display_name":"Renaud Ronald C JR","owner_url":"/insider/0001354434","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-11","filed_date":"2008-03-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001805387","name":"Cerevel Therapeutics Holdings, Inc.","url":"/issuer/0001805387","role":"Director, Officer (President & CEO)","n_filings":1,"first_seen":"2023-08-07","last_seen":"2023-08-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001693415","name":"Translate Bio, Inc.","url":"/issuer/0001693415","role":"Director, Officer (Chief Executive Officer)","n_filings":1,"first_seen":"2021-09-14","last_seen":"2021-09-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001517022","name":"Akebia Therapeutics, Inc.","url":"/issuer/0001517022","role":"Director","n_filings":1,"first_seen":"2014-12-02","last_seen":"2014-12-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001093649","name":"IDENIX PHARMACEUTICALS INC","url":"/issuer/0001093649","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2008-03-11","last_seen":"2008-03-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001354434","retrieved_at":"2026-08-25T21:35:11+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}